News
CRDL Cardiol Therapeutics, Inc. (TOR)
-
- Last: 1.47
- Change: +0.13 (+9.33%)
| Cardiol Therapeutics Announces Bought Deal Financing for Gross Proceeds of $13.5 Million — Comtex08:47 AM ET 01/16/2026 Toronto, Ontario, Jan 16, 2026 (Newsfile Corp via COMTEX News Network) -- Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or... |
| Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million — Comtex08:42 AM ET 01/16/2026 Toronto, Ontario, Jan 16, 2026 (Newsfile Corp via COMTEX News Network) -- Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or... |
| Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis — Comtex07:56 AM ET 01/13/2026 Toronto, Ontario--(Newsfile Corp. - January 13, 2026) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company focused on advancing... |
| New Data from the Phase II ARCHER Trial Demonstrate CardiolRx(TM) Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions — Comtex07:28 AM ET 12/01/2025 Toronto, Ontario--(Newsfile Corp. - December 1, 2025) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company advancing... |
Quotes delayed at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement.